Mo1 - Combining Internally Valid Trial Evidence With Generalizable Real-World Data: Insights Into Effects, Costs, and Cost-Effectiveness of Novel Treatment Sequences in Patients With Multiple Myeloma
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.061
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV